Loading...
Docoh

Chembio Diagnostics (CEMI)

News

From Benzinga Pro
110 Biggest Movers From Friday
16 May 22
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares jumped 154.9% to close at $0.51. ShiftPixy reported board approval special dividend to shareholders in form of common shares of Industrial Human Capital.
Stocks That Hit 52-Week Lows On Wednesday
11 May 22
News, Options, Intraday Update, Markets, Movers, Trading Ideas
On Wednesday, 807 companies reached new 52-week lows.
92 Biggest Movers From Friday
9 May 22
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers Sidus Space, Inc. (NASDAQ: SIDU) jumped 51.8% to settle at $2.99 on Friday after the company announced a a memorandum of understanding with Dhruva Space to expand its partnership to further the commercialization of space technologies and services.
Earnings Scheduled For May 5, 2022
5 May 22
Earnings, News, Pre-Market Outlook, Markets
Companies Reporting Before The Bell • Mirum Pharmaceuticals (NASDAQ:MIRM) is expected to report quarterly loss at $1.34 per share on revenue of $8.46 million.
12 Health Care Stocks Moving In Friday's After-Market Session
29 Apr 22
Movers
Gainers Ocular Therapeutix (NASDAQ:OCUL) shares moved upwards by 12.3% to $4.01 during Friday's after-market session. The company's market cap stands at $307.7 million.
Stocks That Hit 52-Week Lows On Wednesday
27 Apr 22
News, Options, Intraday Update, Markets, Movers, Trading Ideas
Wednesday's session saw 784 companies set new 52-week lows.
Stocks That Hit 52-Week Lows On Tuesday
26 Apr 22
News, Options, Intraday Update, Markets, Movers, Trading Ideas
During Tuesday, 581 stocks hit new 52-week lows. Interesting Highlights From Today's 52-Week Lows Meta Platforms (NASDAQ:FB) was the biggest company on a market cap basis to set a new 52-week low.
Stocks That Hit 52-Week Lows On Monday
14 Mar 22
News, Options, Intraday Update, Markets, Movers, Trading Ideas
On Monday, 671 companies achieved new lows for the year.
Looking Into Chembio Diagnostics's Return On Capital Employed
9 Mar 22
Earnings
Chembio Diagnostics (NASDAQ:CEMI) brought in sales totaling $20.57 million during Q4 according to data provided by Benzinga Pro. However, earnings decreased 119.5%, resulting in a loss of $13.97 million.
Stocks That Hit 52-Week Lows On Tuesday
8 Mar 22
News, Options, Intraday Update, Markets, Movers, Trading Ideas
Tuesday's session saw 729 companies set new 52-week lows.
68 Biggest Movers From Friday
7 Mar 22
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers Indonesia Energy Corporation Limited (NASDAQ: INDO) shares jumped 101.8% to close at $40.77 on Friday after jumping 39% on Thursday.
43 Stocks Moving In Friday's Mid-Day Session
4 Mar 22
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
Gainers VEON Ltd. (NASDAQ: VEON) rose 45.6% to $0.3830 after dropping 41% on Thursday.
Despite More Than Double Q4 Sales, Chembio Diagnostics Posts Deeper Losses
4 Mar 22
Earnings, News, Penny Stocks, Health Care, Movers, Trading Ideas, General
12 Health Care Stocks Moving In Friday's Pre-Market Session
4 Mar 22
Pre-Market Outlook, Markets, Movers
Why Chembio Diagnostics Shares Are Falling
4 Mar 22
Movers, Trading Ideas
Chembio Diagnostics Inc (NASDAQ: CEMI) shares are trading lower by 12.4% at $0.81 after the company reported worse-than-expected fourth-quarter adjusted EPS results.
The Daily Biotech Pulse: Ocugen Faces Regulatory Setback, vTv CEO Quits, Biogen-Eisai Make Headway With Second Alzheimer's Antibody Treatment In Japan
4 Mar 22
Biotech, Earnings, News, Penny Stocks, Offerings, Small Cap, FDA, General
Here's a roundup of top developments in the biotech space over the last 24 hours.
24 Stocks Moving in Friday's Pre-Market Session
4 Mar 22
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers Statera Biopharma, Inc. (NASDAQ: STAB) rose 30.4% to $0.9520 in pre-market trading. Statera Biopharma recently submitted Phase 1 clinical trial protocol to the FDA for investigational treatment of long-haul COVID-19.
UPDATE: Chembio Diagnostics Q4 Adj. EPS $(0.32) Misses $(0.20) Estimate, Sales $20.57M Beat $13.55M Estimate
3 Mar 22
Earnings, News
Chembio Diagnostics (NASDAQ:CEMI) reported quarterly losses of $(0.32) per share which missed the analyst consensus estimate of $(0.20) by 60 percent. This is a 8.57 percent increase over losses of $(0.35) per share from
Chembio Diagnostics Q4 GAAP EPS $(0.47) Down From $(0.35) YoY, Sales $20.60M Beat $13.55M Estimate
3 Mar 22
Earnings, News
Chembio Diagnostics (NASDAQ:CEMI) reported quarterly losses of $(0.47) per share. This is a 34.29 percent decrease over losses of $(0.35) per share from the same period last year. The company reported quarterly sales of
Earnings Scheduled For March 3, 2022
3 Mar 22
Earnings, News, Pre-Market Outlook, Markets
Companies Reporting Before The Bell • Travelzoo (NASDAQ:TZOO) is expected to report quarterly earnings at $0.13 per share on revenue of $18.23 million.